Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) just unveiled an announcement.
TheraCryf Plc, a UK-based company, has experienced a significant change in its shareholder structure. Tracarta Limited, based in the British Virgin Islands, has acquired 18.78% of the voting rights in TheraCryf Plc, marking a notable shift from a previous position of 0%. This acquisition could potentially impact TheraCryf’s strategic decisions and influence its market position.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For detailed information about TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue